Raphael Bueno Selected Research

Disease Progression

1/2024	The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
10/2010	Semi-supervised recursively partitioned mixture models for identifying cancer subtypes.
8/2008	Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael Bueno Research Topics

Disease

107	Neoplasms (Cancer) 04/2024 - 05/2002
48	Mesothelioma 04/2024 - 05/2002
41	Malignant Mesothelioma 01/2023 - 05/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 02/2003
21	Lung Neoplasms (Lung Cancer) 12/2021 - 02/2004
10	Adenocarcinoma 11/2023 - 12/2003
7	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 03/2009
6	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2013
5	Adenocarcinoma of Lung 02/2024 - 09/2003
5	Carcinoma (Carcinomatosis) 11/2023 - 11/2011
5	Neoplasm Metastasis (Metastasis) 04/2014 - 02/2003
4	Carcinogenesis 01/2024 - 05/2002
4	Inflammation (Inflammations) 12/2021 - 03/2012
3	Disease Progression 01/2024 - 08/2008
3	Infections 01/2022 - 07/2004
3	Pneumonia (Pneumonitis) 01/2021 - 07/2006
3	Heart Arrest (Cardiac Arrest) 04/2008 - 07/2004
2	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 04/2021
2	Empyema 10/2022 - 07/2004
2	Emphysema 02/2021 - 03/2009
2	Adenocarcinoma in Situ 01/2021 - 12/2017
2	Hyperplasia 01/2021 - 12/2017
2	Fistula 01/2021 - 07/2004
2	Pathologic Constriction (Stenosis) 01/2021 - 05/2003
2	Embolism (Embolus) 10/2020 - 07/2004
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 07/2004
2	Lung Diseases (Lung Disease) 03/2017 - 02/2006
2	Pulmonary Edema 06/2014 - 06/2008
2	Sepsis (Septicemia) 12/2013 - 02/2007
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2013 - 07/2004
2	Hemorrhage 05/2009 - 07/2004
2	Dyspnea (Shortness of Breath) 02/2007 - 12/2002
2	Melanoma (Melanoma, Malignant) 09/2003 - 02/2003
1	Low Vision (Subnormal Vision) 02/2024
1	Pain (Aches) 02/2024

Drug/Important Bio-Agent (IBA)

17	AsbestosIBA 04/2024 - 07/2002
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2002
13	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 06/2002
10	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2003
10	Messenger RNA (mRNA)IBA 01/2021 - 06/2002
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2009
5	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2002
4	1-methyl-1-piperidinomethane sulfonateIBA 05/2013 - 03/2008
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2012 - 02/2004
3	MesothelinIBA 04/2024 - 08/2011
3	B7-H1 AntigenIBA 01/2020 - 02/2016
3	CytokinesIBA 01/2018 - 03/2012
3	Gemcitabine FDA Link 01/2018 - 11/2008
3	Formaldehyde (Formol)FDA Link 01/2017 - 01/2015
3	SuspensionsIBA 12/2016 - 02/2003
3	Bortezomib (Velcade)FDA Link 01/2016 - 04/2008
2	CollagenIBA 05/2024 - 06/2023
2	LigandsIBA 02/2024 - 01/2019
2	Drug CombinationsIBA 01/2023 - 01/2021
2	Neurofibromin 2 (Merlin)IBA 10/2022 - 10/2016
2	Keratins (Keratin)IBA 12/2021 - 11/2008
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020 - 07/2002
2	Small Cytoplasmic RNAIBA 01/2020 - 01/2019
2	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2017
2	AntibodiesIBA 01/2018 - 02/2016
2	ParaffinIBA 01/2017 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 03/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 11/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2016 - 01/2013
2	Pemetrexed (MTA)FDA Link 01/2016 - 04/2008
2	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 01/2015 - 01/2014
2	MTOR InhibitorsIBA 01/2014 - 11/2008
2	Hemoglobins (Hemoglobin)IBA 04/2013 - 02/2012
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2012 - 11/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 01/2008
2	Oxygen (Dioxygen)IBA 02/2006 - 06/2005
2	OligonucleotidesIBA 06/2005 - 06/2005
2	Collagen Type IV (Type IV Collagen)IBA 04/2005 - 08/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003 - 02/2003
1	AntigensIBA 04/2024
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 02/2024
1	Morphine (MS Contin)FDA LinkGeneric 02/2024

Therapy/Procedure

42	Therapeutics 02/2024 - 05/2003
21	Drug Therapy (Chemotherapy) 03/2023 - 03/2005
20	Pneumonectomy (Lung Volume Reduction) 11/2021 - 12/2002
11	Neoadjuvant Therapy 11/2023 - 03/2005
9	Radiotherapy 01/2019 - 07/2006
8	Esophagectomy 11/2023 - 01/2015
7	Immunotherapy 02/2024 - 01/2016
5	Cytoreduction Surgical Procedures 02/2023 - 05/2009
5	Adjuvant Chemotherapy 01/2022 - 07/2006
3	Segmental Mastectomy (Lumpectomy) 04/2024 - 02/2021
3	Operative Surgical Procedures 02/2023 - 03/2010
3	Length of Stay 10/2022 - 04/2021
3	Thoracotomy 01/2016 - 02/2004
2	Precision Medicine 01/2023 - 01/2021
2	Operative Time 04/2021 - 02/2007
2	Catheters 01/2020 - 07/2004
2	Pericardiectomy 11/2018 - 04/2008
2	Chemoradiotherapy 01/2015 - 03/2008
2	Aftercare (After-Treatment) 09/2009 - 07/2006
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 06/2007 - 04/2004
2	Mechanical Ventilators (Ventilator) 02/2007 - 06/2005
1	Epidural Analgesia 02/2024